Structure-activity relationship studies with (+/-)-nantenine derivatives for 1 -adrenoceptor antagonist activity

By Indra B.   Matsunaga K.   Hoshino O.   Suzuki M.   Ogasawara H.   Ohizumi Y.  

European Journal of Pharmacology, Vol. 437, Iss. 3, 2002-02 ,pp. : 173-178

Elsevier

Access to resources Recommend Favorite

Correction of neurovascular deficits in diabetic rats by 2 -adrenoceptor agonist and 1 -adrenoceptor antagonist treatment: Interactions with the nitric oxide system

By Cotter M.A.   Cameron N.E.  

European Journal of Pharmacology, Vol. 343, Iss. 2, 1998-02 ,pp. : 217-223

Elsevier

Access to resources Recommend Favorite

D 1 Agonist and/or D 2 antagonist dopamine receptor properties of a series of ergoline derivatives: a structure-activity study

By Mantegani S.   Arlandini E.   Bandiera T.   Borghi D.   Brambilla E.   Caccia C.   Cervini M.A.   Cremonesi P.   McArthur R.A.   Traquandi G.   Varasi M.  

European Journal of Medicinal Chemistry, Vol. 34, Iss. 2, 1999-02 ,pp. : 107-124

Elsevier

Access to resources Recommend Favorite

Anti-tumour Activity of Some Polydentate N-Ligands: N,N-bis-(3- Substituted-5-Methylpyrazol-1yl Methyl) Arylamines and N,N,N',N'-Tetra- [(3-Substituted-5-Methylpyrazol-1yl] Para-Phenylenediamines

By  

Letters in Drug Design & Discovery, Vol. 2, Iss. 8, 2005-12 ,pp. : 584-589

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and post-coital contraceptive activity of a new series of substituted 2,3-diaryl-2H-1-benzopyrans

By Hajela K.   Kapil R.  

European Journal of Medicinal Chemistry, Vol. 32, Iss. 2, 1997-01 ,pp. : 135-142

Elsevier

Access to resources Recommend Favorite